Skip to main content

Table 3 Intervention adherence

From: Healthy at home for COPD: an integrated digital monitoring, treatment, and pulmonary rehabilitation intervention

 

All Participants

(N = 100)

Patient Activation Measure Level 1–2

(n = 9)

Patient Activation Measure Level 3

(n = 30)

Patient Activation Measure Level 4

(n = 51)

Smartwatch Use

    

 Median Daily Hours worn (IQR)

18.9 (16–20)

18.8 (16–22)

18.9 (17–21)

18.9 (17–20)

 Median Days worn (IQR)

114 (30–210)

179 (150–203)

81 (30–243)

105 (34–244)

 Median Daily Minutes of heartrate detection (IQR)

1034 (939–1133)

1127 (932–1251)

1135 (1008–1259)

1135 (1041–1229)

Completed Responses to Study Instruments

    

 Scheduled (n,%)

    

 Baseline Demographics (month 0)

93 (93)

9 (100)

30 (100)

51 (100)

 COPD Assessment Test

91 (91)

9 (100)

30(100)

51 (100)

 NIH-PROMIS COPD

90 (90)

9 (100)

30(100)

51(100)

 Patient Activation Measure

91 (91)

9 (100)

30(100)

51(100)

 mMRC (Modified Medical Research Council) Dyspnea Scale

90 (90)

9 (100)

30 (100)

51(100)

 Patient Satisfaction (baseline)

87 (87)

9 (100)

29 (93.5)

50 (98.0)

 Patient Satisfaction (3 and 6 month)

78 (78)

9 (100)

25 (80.1)

47 (92.2)

 Single-item wellness

93 (93)

9 (100)

29 (93.5)

51(100)

Ad Hoc

    

 CLEAR Sx

    

 Patients with at least 1 complete (n, %)

85 (85)

9 (100)

27 (87.1)

47 (92.2)

 Total CLEAR Sx completed (mean per patient)

485 (4.85)

102 (11.3)

144 (4.6)

249 (4.9)

Tele-Pulmonary-rehabilitation Engagement

    

 Opted In

55 (55)

8(88.8)

16 (51.6)

31 (60.8)

 No opt in

45 (45)

1 (11.1)

14 (45.2)

20 (39.2)

Healthcare Utilization

    

 Any ambulatory encounter within 72 h of CLEAR Sx

53

6

20

25

 MIH Encounters within 72 h of CLEAR Sx

3

0

0

3

 MIH Encounters independent of CLEAR Sx

67

0

24

43

 ED visit with no preceding CLEAR Sx Survey

1

0

0

1